|Videos|June 27, 2023

Visibility and Risk Management with Overhaul

Author(s)Amy Shortman

Amy Shortman, Overhaul, explains the importance of visibility for risk management and compliance issues when navigating the supply chain and highlights solutions to support life sciences.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Content

Gregg Gorniak

Gregg Gorniak: What Changed in Five Years of DSCSA?

ByGregg Gorniak,Stephen Appezzato

September 11th 2026

Kala Shankle

Kala Shankle on What Comes Next for National Licensure

ByKala Shankle, JD,Stephen Appezzato

September 10th 2026

Pills stacked against money background, toned in blue | © Enso - stock.adobe.com 343271169

FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers

ByStephen Appezzato

September 9th 2026

Liberty Dewey

Why the Biggest NDC-12 Risk Sits in the Handoffs

ByLiberty Dewey,Stephen Appezzato

September 9th 2026

Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient's home.

The Transition to Home: Why Confidence is Critical to Patient Success

ByJoe Reynolds, Noble

September 9th 2026

Sponsored

Trending on Pharmaceutical Commerce

FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers

Why Pharma's Next AI Challenge Is Supervision, Not Adoption

Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market

A Complex Chess Game With Invisible Chess Pieces

How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain